SCHEMBL8048744

SCHEMBL8048744

NC(=O)CCCCC1=CCC=CC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MPO P05164 2/20 0.31
TBXAS1 P24557 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17611060 0.80 HDAC3 (0.41)
SCHEMBL10943194 0.77 CA2 (0.33)
SCHEMBL379058 0.75
SCHEMBL2357992 0.73 HTR2A (0.35) TBXAS1
SCHEMBL7494175 0.72
SCHEMBL12394193 0.72
SCHEMBL23630610 0.68 TAAR1 (0.35)
SCHEMBL6748342 0.67 F13A1 (0.53) TBXAS1
SCHEMBL6751710 0.67 F13A1 (0.53) TBXAS1
SCHEMBL3973741 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6072046-A SELECTIVELY FORM TRIPLEXES WITH A COMPLEMENTARY TARGET SEQUENCE IN DOUBLE-STRANDED DNA AND EFFICIENTLY CROSSLINK WITH BOTH STRANDS; THERAPEUTICS, DIAGNOSTICS, AND GENETIC PROBES EPOCH PHARMACEUTICALS, INC. (US) 2000-06-06 US disclosed